A landmark partnership will help to accelerate the future development, manufacture and distribution of a University of Queensland COVID-19 vaccine.
Key points:
- Global biotechnology company CSL will further develop, manufacture and distribute UQ’s COVID-19 vaccine candidate.
- The UQ vaccine is expected to be available in 2021 should clinical trials be successful.
CSL Chief Scientific Officer Professor Andrew Cuthbertson said the devastating toll COVID-19 had inflicted on the world was being countered by an extraordinary effort from scientists who have crossed borders and boundaries to collaborate, pool resources and make progress at a rate not seen before.
“Should trials be successful, this vaccine holds the potential to provide protection against this urgent public health emergency for Australians and those around the world who are vulnerable to this devastating virus,” Professor Cuthbertson said.
